13F HOLDINGS REPORT
Column Group LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0000950123-24-005685
Total Value
$160.5M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Tenaya Therapeutics, Inc. | TNYA | 9,400,290 | $49.2M | 30.62% |
| 2 | ORIC Pharmaceuticals Inc. | ORIC | 3,540,777 | $48.7M | 30.33% |
| 3 | NGM Biopharmaceuticals Inc | 62921N105 | 18,136,735 | $28.8M | 17.96% |
| 4 | RAPT Therapeutics Inc | 75382E109 | 2,680,621 | $24.1M | 14.99% |
| 5 | Surrozen, Inc. | SRZNW | 616,540 | $9.7M | 6.03% |
| 6 | Sagimet Biosciences Inc. | SGMT | 17,169 | $93,056 | 0.06% |
| 7 | Revolution Medicines Inc | RVMDW | 46 | $1,483 | 0.00% |